PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 70 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,945 | +2.2% | 7,102 | +48.8% | 0.00% | – |
| Q2 2023 | $21,474 | -42.0% | 4,772 | -11.2% | 0.00% | – |
| Q1 2022 | $37,000 | -48.6% | 5,373 | -6.6% | 0.00% | – |
| Q4 2021 | $72,000 | -61.1% | 5,751 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $185,000 | +6.3% | 5,923 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $174,000 | -30.4% | 6,064 | +5.0% | 0.00% | 0.0% |
| Q1 2021 | $250,000 | -34.6% | 5,776 | +8.2% | 0.00% | 0.0% |
| Q4 2020 | $382,000 | – | 5,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,909,256 | $33,709,601 | 0.72% |
| Boxer Capital, LLC | 2,495,018 | $7,709,606 | 0.41% |
| Sio Capital Management, LLC | 350,000 | $1,081,500 | 0.34% |
| Baker Brothers Advisors | 10,123,824 | $31,282,616 | 0.18% |
| EcoR1 Capital, LLC | 1,157,452 | $3,576,527 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 70,583 | $218 | 0.02% |
| Pale Fire Capital SE | 30,781 | $95,113 | 0.01% |
| Woodline Partners LP | 200,000 | $618,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 143,957 | $444,827 | 0.00% |
| EXCHANGE TRADED CONCEPTS, LLC | 32,907 | $101,683 | 0.00% |